All Rankings

Recently Funded Biotech Companies in the US 2026 (Last 180 Days)

Private biotechnology and genomics companies headquartered in the United States whose latest recorded funding round was announced in the last 180 days, newest first.

Known total funding for 99 of 100 ranked companies: $18.7B.

Showing top 100 matching companies · Ranked by most recent funding

Use company data through the API.
Example request
curl "https://indexed.vc/api/v1/companies?industries=Biotech,Genomics&countries=United+States&fundedAfter=2026-05-23&operatingStatus=active&sort=last_funding_date&order=desc&limit=100" -H "X-API-Key: YOUR_API_KEY"

The API can include out-of-scope company records; this core research list excludes them.

The API has no company type filter, so public companies can appear; this list counts private companies only.

The API cannot leave out companies whose latest round is a grant; this list does.

Data from Indexed.vcUpdated

Methodology: up to 100 active companies matching this list's filters are ordered by most recent announced round. Companies whose latest round is one of: Grant are excluded. Totals include recorded grants and other qualifying funding, not just equity. Open a company profile for its funding summary and available detail. How this data is built.

76
Zumutor

Zumutor Biologics is an immuno-oncology company developing targeted NK cell therapeutics using it...

Cambridge, United States11–50Biotech, Healthcare
Venture RoundTotal funding$30.8MJun 2026
77
Ethyreal Bio

Biotech developing ETHY-001, a best-in-class anti-TSHR antibody targeting root causes of Graves' ...

San Francisco, United States1–10Biotech, Healthcare
SeedTotal funding$101.0MJun 2026
78
Neion Bio

Neion Bio is a biotechnology company that harnesses nature's best protein factories to make medic...

New York, United States1–10Biotech
Series ATotal funding$34.0MJun 2026
79
SonoThera

Ultrasound-mediated non-viral gene therapy platform for non-invasive, targeted genetic medicine d...

South San Francisco, United States11–50Biotech, Healthcare
Series BTotal funding$185.8MJun 2026
80
NewLeaf Symbiotics

NewLeaf Symbiotics is a biological technology provider whose specialty is Pink-Pigmented Facultat...

St. Louis, United States11–50Agtech, Biotech
Series ATotal funding$161.0MJun 2026
81
Sampled

Next-generation laboratory providing storage, management, analysis, and transportation for biolog...

Piscataway, United States51–200Biotech, Healthcare
Pre-seedTotal funding$500KJun 2026
82
City Therapeutics

Biopharmaceutical company building next-generation RNAi therapeutics to improve treatment for pat...

Cambridge, United States51–200Biotech, Healthcare
Series BTotal funding$234.5MJun 2026
83
Waypoint Bio

Waypoint Bio develops AI-designed cell therapies by combining spatial pooled screening, in situ g...

New York, United States11–50Artificial Intelligence, Biotech
Series ATotal funding$34.5MJun 2026
84
Mediar Therapeutics

Mediar develops novel fibrosis treatments that disable myofibroblasts, aiming to slow or reverse ...

Cambridge, United States11–50Biotech, Healthcare
Series BTotal funding$282.0MJun 2026
85
StraiNX Bioworks

Synthetic biology company using precision fermentation to create sustainable, high-value biomolec...

Bhopal, United States11–50Biotech, Deep Tech
Series ATotal funding$20.6MJun 2026
86
Ona Therapeutics

Biotechnology company spun out of ICREA and IRB that unravels novel biology to design biotherapeu...

Barcelona, United States11–50Biotech, Healthcare
Series BTotal funding$152.1MJun 2026
87
Artis BioSolutions

Streamlining the discovery, development and production of genetic medicines

Boston, United States51–200Biotech, Healthcare
Series ATotal funding$30.0MJun 2026
88
August Bioservices

August Bioservices is a Nashville-based CDMO that provides contract research, development, and ma...

Nashville, United States51–200Biotech
Series ATotal funding$158.6MJun 2026
89
Contraline

Contraline develops investigational male contraceptives, including ADAM, a long-lasting reversibl...

Charlottesville, United States11–50Biotech, Healthcare
Series BTotal funding$132.4MJun 2026
90
NewLimit

NewLimit develops medicines that unlock cellular regenerative potential to extend human healthspa...

South San Francisco, United States11–50Biotech, Healthcare
Venture RoundTotal funding$735.0MJun 2026
91
Tavo Biotherapeutics

Biotech company developing novel therapeutics for glaucoma and retinal disease, focused on breakt...

Laguna Beach, United States1–10Biotech, Healthcare
Series ATotal funding$17.0MJun 2026
92
Anodyne Nanotech

Anodyne Nanotech is a clinical-stage biotech company, developing transdermal premium products for...

Boston, United States11–50Biotech, Drug Discovery
Series ATotal funding$12.6MJun 2026
93
Element Biosciences

Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...

San Diego, United States201–500Biotech, Genomics
Series ETotal funding$853.3MJun 2026
94
Lila Sciences

Lila Sciences combines artificial intelligence with autonomous laboratories to accelerate scienti...

Cambridge, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.3BJun 2026
95
Oak Hill Biosciences

Public company, acquired

Cambridge, United States11–50Biotech
Series ATotal funding$32.5MJun 2026
96
Psilera

Neuroplastogen drug development company targeting mental health conditions.

Tampa, United States1–10Biotech, Healthcare
SeedTotal funding$39.3MMay 2026
97
ClearNote Health

ClearNote Health develops blood-based early cancer detection tests and precision research tools u...

San Diego, United States11–50Healthcare, Biotech
Series ATotal funding$193.8MMay 2026
98
Cypher AI

Cypher AI provides intelligent digital infrastructure for life sciences R&D, generating experimen...

Cambridge, United States1–10Artificial Intelligence, Biotech
SeedTotal funding$2.0MMay 2026
99
Ember LifeSciences

Ember LifeSciences provides dependable cold-chain solutions that maintain precise temperature con...

Westlake Village, United States11–50Biotech
Series ATotal funding$43.5MMay 2026
100
Secretome Therapeutics

Secretome Therapeutics develops novel therapies from neonatal cardiac progenitor cells, with an i...

Baltimore, United States1–10Biotech
Series ATotal funding$52.4MMay 2026